← Scroll for more →
Immix Biopharma, Inc. (IMMX)
Pharmaceutical Preparations
Latest Price
$8.05
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.21
P/B Ratio
1.91
Institutional Ownership
78.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 9.78M | $100.0M | 13.68% | -- | 2026-06-30 |
| Saturn V Capital Management LP | 4.66M | $48.0M | 6.51% | +964.8K | 2026-06-30 |
| Eventide Asset Management, LLC | 3.89M | $40.0M | 5.44% | +1.34M | 2026-06-30 |
| State Street Corp | 3.00M | $30.0M | 4.19% | +2.81M | 2026-06-30 |
| BlackRock, Inc. | 2.99M | $30.0M | 4.18% | +2.52M | 2026-06-30 |
| Deep Track Capital, LP | 2.77M | $28.0M | 3.88% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 2.51M | $25.0M | 3.50% | +719.1K | 2026-06-30 |
| Opaleye Management Inc. | 2.35M | $24.0M | 3.28% | -- | 2026-06-30 |
| Millennium Management LLC | 2.07M | $21.0M | 2.89% | +316.2K | 2026-06-30 |
| UBS Group AG | 1.94M | $20.0M | 2.71% | +1.86M | 2026-06-30 |